GSK-Projecten SRL
GSK-Projecten reported total assets of 66,083 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jan 2026).
The score of GSK-Projecten shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +26 % Total assets -70 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
GSK-Projecten's annual accounts
Filed annual accounts
- Year ended 30 Jun 2025filed on 30 Jan 2026
- Year ended 30 Jun 2024filed on 09 Jan 2025
- Year ended 30 Jun 2023filed on 11 Jan 2024
- Year ended 30 Jun 2022filed on 26 Dec 2022
- Year ended 30 Jun 2021filed on 15 Dec 2021
GSK-Projecten's financial analysis
- Solvency88.7%sector median: 23.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of GSK-Projecten
GSK-Projecten's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0890.187.608
- VAT number
- BE0890187608
- Peppol
- Registered · 0208:0890187608 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 31 May 2007
- Registered office
- 3500 Hasselt
- Latest accounts
- 2025 · filed on 30 Jan 2026
- Activity
- Development of residential building projects (NACE 68121)
GSK-Projecten (SRL) has been based in Hasselt since 2007, active in: development of residential building projects. For 2025, it reports a net profit of 1,748 € and equity of 58,618 €; its revenue is not published. Its solvency stands at 88.7%, above the median of its sector (23.4%).
Companies similar to GSK-Projecten
Companies in the same business, of comparable size and area, outside its group.
- Private Deals Development of building projects Montigny-le-Tilleul · balance sheet 59,738 €
- CRE-D.T. Development of building projects Antwerp · balance sheet 53,804 €
- Berson Invest Development of building projects Molenbeek-Saint-Jean · balance sheet 71,301 €
- Urban 28 Development of building projects Uccle · balance sheet 116,812 €
- FAZ Invest Development of building projects Herstal · balance sheet 247,722 €
- BlackWall Development of building projects Ixelles · balance sheet 692,081 €
- Biome Projets Development of building projects Gedinne · balance sheet €1.36m
- Solter Development of building projects Lummen · balance sheet 32,346 €
Frequently asked questions about GSK-Projecten
What is the revenue of GSK-Projecten?
GSK-Projecten files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of GSK-Projecten?
In Belgium, the VAT number is the company number prefixed with BE: BE0890187608 for GSK-Projecten, if the company is VAT-registered. Its company number (CBE) is 0890.187.608.
Where is the registered office of GSK-Projecten?
According to the CBE register, the registered office of GSK-Projecten is in 3500 Hasselt.
What is the equity of GSK-Projecten?
At the close of the 2025 financial year, the equity of GSK-Projecten amounts to 58,618 €, a solvency of 88.7% of total assets.
Who manages GSK-Projecten?
The register lists 1 active mandates at GSK-Projecten. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of GSK-Projecten
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →